Preincubation of these cells with anti-CD164 MAb N6B6 blocked rLCMV-mCherry infection, with a treatment of 25 μg/mL N6B6 reducing the detection of mCherry-positive cells by 84% and 125 μg/mL reducing infection further by 94% (Fig. 4B and C). The gene discussed is CD164; the disease is infection.